1. Home
  2. AMZE vs SNGX Comparison

AMZE vs SNGX Comparison

Compare AMZE & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amaze Holdings Inc.

AMZE

Amaze Holdings Inc.

HOLD

Current Price

$0.12

Market Cap

5.3M

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.38

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMZE
SNGX
Founded
2019
1987
Country
United States
United States
Employees
28
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.6M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
AMZE
SNGX
Price
$0.12
$0.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$6.00
AVG Volume (30 Days)
3.9M
814.2K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
N/A
$119,371.00
Revenue This Year
$1,986.62
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.28
52 Week High
$11.70
$6.23

Technical Indicators

Market Signals
Indicator
AMZE
SNGX
Relative Strength Index (RSI) 42.82 39.23
Support Level $0.12 $0.37
Resistance Level $0.20 $0.41
Average True Range (ATR) 0.01 0.02
MACD -0.00 0.01
Stochastic Oscillator 16.80 14.65

Price Performance

Historical Comparison
AMZE
SNGX

About AMZE Amaze Holdings Inc.

Amaze Holdings Inc is a technology-enabled, creator-powered commerce platform that enables creators, brands, and consumers to transact at scale. The Company provides infrastructure for creators and brands to design, launch, market, and fulfill products. The Company operates in two segments: E-commerce / Subscriptions, which includes the Amaze platform and creator commerce operations supporting product sales, subscription offerings, and digital content delivery; and Wine Products, which includes the sale of Fresh Vine wines through wholesale and direct-to-consumer channels across the United States and Puerto Rico.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: